AJP - Regu Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 290: R331-R340, 2006. First published September 29, 2005; doi:10.1152/ajpregu.00317.2005
0363-6119/06 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/2/R331    most recent
00317.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eppel, G. A.
Right arrow Articles by Evans, R. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eppel, G. A.
Right arrow Articles by Evans, R. G.

RENAL HEMODYNAMICS AND CARDIORENAL INTEGRATION

Type 1 neuropeptide Y receptors and {alpha}1-adrenoceptors in the neural control of regional renal perfusion

Gabriela A. Eppel,1 Susan E. Luff,2 Kate M. Denton,1 and Roger G. Evans1

1Department of Physiology and 2Monash Micro Imaging, Monash University, Melbourne, Australia

Submitted 4 May 2005 ; accepted in final form 22 September 2005

The aim of this study was to determine the contribution of neuropeptide Y (NPY) Y1 receptors in neurally mediated reductions in renal medullary perfusion. In pentobarbital sodium-anesthetized rabbits, electrical stimulation of the renal nerves (RNS, 0.5–16 Hz) decreased renal perfusion in a frequency-dependent manner. Under control conditions, 4 Hz reduced cortical and medullary perfusion by –85 ± 3% and –43 ± 7%, whereas 8 Hz reduced them by –93 ± 2% and –73 ± 4%, respectively. After Y1 receptor antagonism with BIBO3304TF (0.1 mg/kg plus 0.2 mg·kg·–1·h–1), RNS reduced perfusion less (by –65 ± 9% and –12 ± 8% at 4 Hz). {alpha}1-Adrenoceptor antagonism with prazosin (0.2 mg/kg plus 0.2 mg kg–1h–1) also inhibited RNS-induced reductions in renal perfusion (–80 ± 4% and –37 ± 10% reductions in the cortex and medulla, respectively, at 8 Hz). When given after BIBO3304TF treatment, prazosin inhibited RNS-induced reductions in cortical and medullary perfusion more profoundly (–57 ± 12% and –25 ± 9% reductions, respectively, at 8 Hz). Y1 receptor- and {alpha}1-adrenoceptor-blockade were confirmed by testing vascular responses to renal arterial NPY and phenylephrine boluses. NPY-positive immunolabeling was observed around interlobular arteries, afferent and efferent arterioles, and in the outer medulla. In conclusion, Y1 receptors and {alpha}1-adrenoceptors contribute to RNS-induced vasoconstriction in the vessels that control both cortical and medullary perfusion. Consistent with this, NPY immunostaining was associated with blood vessels that control perfusion in both regions. There also seems to be an interaction between Y1 receptors and {alpha}1-adrenoceptor-mediated neurotransmission in the control of renal perfusion.

renal medullary blood flow; sympathetic nervous system; BIBO3304TF



Address for reprint requests and other correspondence: G. Eppel, Dept. of Physiology, PO Box 13F, Monash Univ., VIC 3800 Australia (e-mail: gabriela.eppel{at}med.monash.edu.au)




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
N. W. Rajapakse, G. A. Eppel, R. E. Widdop, and R. G. Evans
ANG II type 2 receptors and neural control of intrarenal blood flow
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2006; 291(6): R1669 - R1676.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.